Prognostic significance of O6-methylguanine-DNA methyltransferase promoter methylation status in isocitrate dehydrogenase-mutant glioma
Year: 2025
Type: article
Language: en
Topic: Glioma Diagnosis and Treatment
Authors and affiliations:
raw_author_name: Gilbert Youssef
raw_affiliation_strings: Center for Neuro-Oncology, Dana-Farber Cancer Institute , Boston
Harvard Medical School, Harvard University , Boston
Harvard Medical School, Harvard University, Boston, MA, United States
Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, United States
raw_author_name: Elisa Aquilanti
raw_affiliation_strings: Center for Neuro-Oncology, Dana-Farber Cancer Institute , Boston
Harvard Medical School, Harvard University , Boston
Harvard Medical School, Harvard University, Boston, MA, United States
Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, United States
raw_author_name: Julie J Miller
raw_affiliation_strings: Harvard Medical School, Harvard University , Boston
Pappas Center for Neuro-Oncology, Department of Neurology, Massachusetts General Hospital , Boston
Harvard Medical School, Harvard University, Boston, MA, United States
Pappas Center for Neuro-Oncology, Department of Neurology, Massachusetts General Hospital, Boston, MA, United States
raw_author_name: Zhou Lan
raw_affiliation_strings: Center for Clinical Investigation, Brigham and Women’s Hospital , Boston
Harvard Medical School, Harvard University , Boston
Center for Clinical Investigation, Brigham and Women's Hospital, Boston, MA, United States
Harvard Medical School, Harvard University, Boston, MA, United States
raw_author_name: Aleksandra B Lasica
raw_affiliation_strings: Center for Neuro-Oncology, Dana-Farber Cancer Institute , Boston
Harvard Medical School, Harvard University , Boston
Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, United States
Harvard Medical School, Harvard University, Boston, MA, United States
raw_author_name: Isabel Arrillaga-Romany
raw_affiliation_strings: Harvard Medical School, Harvard University , Boston
Pappas Center for Neuro-Oncology, Department of Neurology, Massachusetts General Hospital , Boston
Pappas Center for Neuro-Oncology, Department of Neurology, Massachusetts General Hospital, Boston, MA, United States
Harvard Medical School, Harvard University, Boston, MA, United States
raw_author_name: Tracy T Batchelor
raw_affiliation_strings: Department of Neurology, Brigham and Women’s Hospital , Boston
Harvard Medical School, Harvard University , Boston
Department of Neurology, Brigham and Women's Hospital, Boston, MA, United States
Harvard Medical School, Harvard University, Boston, MA, United States
raw_author_name: Tamar R Berger
raw_affiliation_strings: Center for Neuro-Oncology, Dana-Farber Cancer Institute , Boston
Harvard Medical School, Harvard University , Boston
Harvard Medical School, Harvard University, Boston, MA, United States
Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, United States
raw_author_name: Rameen Beroukhim
raw_affiliation_strings: Center for Neuro-Oncology, Dana-Farber Cancer Institute , Boston
Harvard Medical School, Harvard University , Boston
Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, United States
Harvard Medical School, Harvard University, Boston, MA, United States
raw_author_name: Ugonma Chukwueke
raw_affiliation_strings: Center for Neuro-Oncology, Dana-Farber Cancer Institute , Boston
Harvard Medical School, Harvard University , Boston
Harvard Medical School, Harvard University, Boston, MA, United States
Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, United States
raw_author_name: Jorg Dietrich
raw_affiliation_strings: Harvard Medical School, Harvard University , Boston
Pappas Center for Neuro-Oncology, Department of Neurology, Massachusetts General Hospital , Boston
Pappas Center for Neuro-Oncology, Department of Neurology, Massachusetts General Hospital, Boston, MA, United States
Harvard Medical School, Harvard University, Boston, MA, United States
raw_author_name: Deborah A Forst
raw_affiliation_strings: Harvard Medical School, Harvard University , Boston
Pappas Center for Neuro-Oncology, Department of Neurology, Massachusetts General Hospital , Boston
Pappas Center for Neuro-Oncology, Department of Neurology, Massachusetts General Hospital, Boston, MA, United States
Harvard Medical School, Harvard University, Boston, MA, United States
raw_author_name: Elizabeth R Gerstner
raw_affiliation_strings: Harvard Medical School, Harvard University , Boston
Pappas Center for Neuro-Oncology, Department of Neurology, Massachusetts General Hospital , Boston
Harvard Medical School, Harvard University, Boston, MA, United States
Pappas Center for Neuro-Oncology, Department of Neurology, Massachusetts General Hospital, Boston, MA, United States
raw_author_name: L Nicolas Gonzalez Castro
raw_affiliation_strings: Center for Neuro-Oncology, Dana-Farber Cancer Institute , Boston
Department of Neurology, Brigham and Women’s Hospital , Boston
Harvard Medical School, Harvard University , Boston
Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, United States
Department of Neurology, Brigham and Women's Hospital, Boston, MA, United States
Harvard Medical School, Harvard University, Boston, MA, United States
raw_author_name: Justin T Jordan
raw_affiliation_strings: Harvard Medical School, Harvard University , Boston
Pappas Center for Neuro-Oncology, Department of Neurology, Massachusetts General Hospital , Boston
Pappas Center for Neuro-Oncology, Department of Neurology, Massachusetts General Hospital, Boston, MA, United States
Harvard Medical School, Harvard University, Boston, MA, United States
raw_author_name: J Ricardo Mcfaline-Figueroa
raw_affiliation_strings: Brain & Spine Tumor Center, Perlmutter Cancer Center, NYU Langone Health , New York
Department of Neurology, Grossman School of Medicine, New York University , New York
Department of Neurology, Grossman School of Medicine, New York University, New York, NY, United States
Brain & Spine Tumor Center, Perlmutter Cancer Center, NYU Langone Health, New York, NY, United States
raw_author_name: Eudocia Quant Lee
raw_affiliation_strings: Center for Neuro-Oncology, Dana-Farber Cancer Institute , Boston
Harvard Medical School, Harvard University , Boston
Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, United States
Harvard Medical School, Harvard University, Boston, MA, United States
raw_author_name: Lakshmi Nayak
raw_affiliation_strings: Center for Neuro-Oncology, Dana-Farber Cancer Institute , Boston
Harvard Medical School, Harvard University , Boston
Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, United States
Harvard Medical School, Harvard University, Boston, MA, United States
raw_author_name: Vihang Nakhate
raw_affiliation_strings: Center for Neuro-Oncology, Dana-Farber Cancer Institute , Boston
Harvard Medical School, Harvard University , Boston
Pappas Center for Neuro-Oncology, Department of Neurology, Massachusetts General Hospital , Boston
Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, United States
Harvard Medical School, Harvard University, Boston, MA, United States
Pappas Center for Neuro-Oncology, Department of Neurology, Massachusetts General Hospital, Boston, MA, United States
raw_author_name: Juan Pablo Ospina
raw_affiliation_strings: Center for Neuro-Oncology, Dana-Farber Cancer Institute , Boston
Harvard Medical School, Harvard University , Boston
Pappas Center for Neuro-Oncology, Department of Neurology, Massachusetts General Hospital , Boston
Pappas Center for Neuro-Oncology, Department of Neurology, Massachusetts General Hospital, Boston, MA, United States
Harvard Medical School, Harvard University, Boston, MA, United States
Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, United States
raw_author_name: Scott R Plotkin
raw_affiliation_strings: Harvard Medical School, Harvard University , Boston
Pappas Center for Neuro-Oncology, Department of Neurology, Massachusetts General Hospital , Boston
Harvard Medical School, Harvard University, Boston, MA, United States
Pappas Center for Neuro-Oncology, Department of Neurology, Massachusetts General Hospital, Boston, MA, United States
raw_author_name: Nancy Wang
raw_affiliation_strings: Harvard Medical School, Harvard University , Boston
Pappas Center for Neuro-Oncology, Department of Neurology, Massachusetts General Hospital , Boston
Harvard Medical School, Harvard University, Boston, MA, United States
Pappas Center for Neuro-Oncology, Department of Neurology, Massachusetts General Hospital, Boston, MA, United States
raw_author_name: John Y Rhee
raw_affiliation_strings: Center for Neuro-Oncology, Dana-Farber Cancer Institute , Boston
Division of Adult Palliative Care, Department of Supportive Oncology, Dana-Farber Cancer Institute , Boston
Harvard Medical School, Harvard University , Boston
Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, United States
Harvard Medical School, Harvard University, Boston, MA, United States
raw_author_name: David A Reardon
raw_affiliation_strings: Center for Neuro-Oncology, Dana-Farber Cancer Institute , Boston
Harvard Medical School, Harvard University , Boston
Harvard Medical School, Harvard University, Boston, MA, United States
Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, United States
raw_author_name: Patrick Y Wen
raw_affiliation_strings: Center for Neuro-Oncology, Dana-Farber Cancer Institute , Boston
Harvard Medical School, Harvard University , Boston
Harvard Medical School, Harvard University, Boston, MA, United States
Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, United States